How Wegovy vs Mounjaro Doses Compare for UK Value
Wegovy vs Mounjaro Doses: UK's Most Competitive Pricing Structure
When comparing Wegovy vs Mounjaro doses in the UK market, pricing transparency becomes crucial for making informed decisions. At EverydayMeds, our Wegovy pricing starts at £79.99 for the 0.25mg starter dose, progressing through £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), to £209.99 for the 2.4mg maintenance dose. Each price includes your clinical consultation, prescription review, and temperature-controlled next-day delivery — no hidden extras or surprise charges.
Mounjaro follows a different dosing pathway, starting at 2.5mg and escalating to 5mg, 7.5mg, 10mg, and 15mg maximum. The key difference lies not just in dosing schedules, but in the underlying mechanisms — Wegovy's semaglutide targets GLP-1 receptors exclusively, whilst Mounjaro's tirzepatide works as a dual GIP and GLP-1 receptor agonist. Both require careful dose escalation under medical supervision, making professional prescriber guidance essential for optimal outcomes.
Complete Wegovy vs Mounjaro Doses Cost Analysis and Bundle Savings
Our pricing structure for Wegovy vs Mounjaro doses reflects the true UK market value, with discount codes applied at checkout to reach these competitive rates. New customers use code FIRST40, whilst returning patients apply DOSE25 for continued savings. Bundle options provide convenience rather than just cost savings — our Intro Trio (0.25mg, 0.5mg, 1mg) costs £299.99, ensuring uninterrupted treatment progression without multiple orders.
The value proposition extends beyond simple pricing when comparing Wegovy vs Mounjaro doses. Wegovy's established STEP trial programme demonstrates average weight loss of approximately 15% at 68 weeks when used alongside a reduced-calorie diet and increased physical activity. Mounjaro's SURMOUNT trials show different results, but direct comparison remains inappropriate due to varying trial designs, participant populations, and endpoints — your prescriber can explain which evidence base applies to your situation.
Clinical Evidence Behind Wegovy vs Mounjaro Doses Selection
The clinical foundation for Wegovy vs Mounjaro doses stems from extensive research programmes designed to establish optimal efficacy and safety profiles. Wegovy's evidence base includes the landmark STEP trials, with STEP 1 showing approximately 15% average weight loss versus 2.4% for placebo at 68 weeks (Wilding et al., NEJM, 2021). STEP 2 demonstrated around 9.6% weight reduction in patients with type 2 diabetes, whilst STEP 3 achieved approximately 16% loss with intensive behavioural support.
Mounjaro's SURMOUNT programme provides its own evidence base for the tirzepatide dosing schedule, though direct head-to-head comparisons between these studies would be inappropriate given different methodologies and participant characteristics. Both treatments require prescription-only access through qualified healthcare providers who can assess individual suitability based on BMI criteria, comorbidities, and personal medical history.
How Wegovy Works: Understanding the GLP-1 Mechanism
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural incretin hormone responsible for blood sugar regulation and appetite control. When injected once weekly, semaglutide binds to GLP-1 receptors in your brain's appetite centres, promoting feelings of fullness and reducing food cravings between meals. This mechanism works by slowing gastric emptying, meaning food stays in your stomach longer, contributing to prolonged satiety after smaller portion sizes. The treatment may also influence reward pathways in the brain that control food-seeking behaviour, potentially reducing the psychological drive to overeat. Clinical studies suggest this dual action on both physiological hunger signals and psychological food motivation contributes to the weight management effects observed in trials, though individual responses may vary significantly.
Streamlined Ordering Process for Wegovy vs Mounjaro Doses
Accessing either Wegovy or Mounjaro through EverydayMeds begins with our comprehensive 3-minute online clinical assessment covering your medical history, current medications, weight management goals, and any relevant health conditions. Your responses undergo review by our qualified prescribers (GPhC #9012878) within 3 working days as standard, or 24 hours with our express service option. Once approved, your prescription-only medicine ships via next-day delivery using temperature-controlled cold-chain logistics to maintain product integrity from our pharmacy to your door. The entire process includes clinical consultation, prescription fees, medication costs, and delivery charges in one transparent price. Payment processing is secure and discreet, with plain packaging ensuring complete privacy throughout your treatment journey.
Storage and Practical Differences: Wegovy vs Mounjaro Doses
Storage requirements present practical advantages when comparing Wegovy vs Mounjaro doses for UK patients with active lifestyles. Wegovy pens remain stable for up to 6 weeks at room temperature (below 30°C) once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit — a significant benefit for business travel, holidays, or situations where refrigeration access becomes limited. Both treatments use pre-filled injection pens with fine needles for subcutaneous administration, typically in the abdomen, thigh, or upper arm. The FlexTouch pen design for Wegovy includes dose escalation from 0.25mg through to 2.4mg maintenance, with mandatory step-wise increases to minimise gastrointestinal side effects. Missing doses or attempting to accelerate the schedule can increase adverse reactions, making adherence to the prescribed Wegovy vs Mounjaro doses timeline essential for optimal tolerance and effectiveness.
Why UK Patients Choose Our Wegovy vs Mounjaro Doses Service
The decision between Wegovy vs Mounjaro doses often comes down to individual factors including medical history, lifestyle preferences, storage needs, and cost considerations. Our UK-based service eliminates many barriers that patients face when accessing weight management treatments through traditional healthcare pathways. Rather than lengthy NHS waiting lists or expensive private clinic consultations, EverydayMeds provides qualified medical oversight with convenient home delivery at competitive pricing.
Patient feedback consistently highlights our transparent pricing structure as a key differentiator in the UK market, where hidden fees and surprise charges have become commonplace. When comparing Wegovy vs Mounjaro doses through other providers, additional consultation fees, prescription charges, and delivery costs can significantly inflate the total treatment expense. Our all-inclusive pricing model ensures you know exactly what you'll pay from the outset, with discount codes providing genuine savings rather than misleading promotional tactics.
Start Your Wegovy Treatment Journey Today
Ready to begin your weight management journey with clinically proven treatment? Our Wegovy pricing starts from just £79.99 for new patients using code FIRST40, or DOSE25 for returning customers — codes applied automatically at checkout. Complete your secure clinical assessment at https://everydaymeds.co.uk/collections/wegovy where our qualified prescribers will review your application and determine the most appropriate starting dose. Remember, both Wegovy and Mounjaro are prescription-only medicines that work best alongside a reduced-calorie diet and increased physical activity. With our GPhC #9012878 registered pharmacy credentials, temperature-controlled delivery, and ongoing support, you're choosing a trusted partner for your long-term health goals. Don't let another day pass wondering about the right choice — start your assessment now and take the first step towards effective weight management.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
